- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Mammography CAD upgrade provides users with flexibility
An upgrade to the computer-aided detection product line from R2 Technology gives users a choice of operating points to set different sensitivity/false marker rates for microcalcifications and masses in the breast. The enhanced system allows users to set sensitivity to their own comfort levels, providing unprecedented flexibility, according to the company.
An upgrade to the computer-aided detection product line from R2 Technology gives users a choice of operating points to set different sensitivity/false marker rates for microcalcifications and masses in the breast. The enhanced system allows users to set sensitivity to their own comfort levels, providing unprecedented flexibility, according to the company.
The flexible operating points feature is part of R2's new software release, ImageChecker Version 8.1 Mammography CAD, which is displayed at the RSNA meeting. This version is being made available across the company's mammography CAD product line and to its entire installed base as an upgrade.
Version 8.1 includes two other major features. The new Malc Mark identifies regions of breast tissue that contain both a mass and calcifications. EmphaSize variable size CAD marks correlate the size of a CAD mark with the potential for malignancy: Small marks reflect a lower chance of malignancy, and large marks indicate more suspicious findings.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
